Fish oil may shield cancer patients from chemo nerve pain
NCT ID NCT05404230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking fish oil supplements can prevent nerve damage in the hands and feet caused by oxaliplatin chemotherapy in colorectal cancer patients. 120 participants will receive either fish oil or corn oil (placebo) during their treatment. The goal is to see if fish oil reduces the number of patients who develop painful nerve symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fish oil (polyunsaturated fatty acids)
- What this could lead to
- If it works, this could provide a simple, low-cost way to prevent painful nerve damage from oxaliplatin chemotherapy.
- What could go wrong
- This is a small, early-stage trial with only 120 participants. The benefit may be small or not work at all, and fish oil supplements can cause mild side effects like fishy aftertaste or stomach upset.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Oncology
RECRUITINGSønderborg, Denmark
-
Department of Oncology, AAUH
RECRUITINGAalborg, Denmark
-
Department of Oncology, AUH
RECRUITINGAarhus, Denmark
-
Department of Oncology, Vejle Hospital
RECRUITINGVejle, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?